Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safinamide as add-on to levodopa in Chinese Parkinson's disease with motor fluctuations
CTR20191025Phase 3Completed
- Sponsor
- Parexel
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of safinamide in Parkinson's disease (PD), sponsored by Parexel. Started May 2019; status: completed.
02
Drugs
safinamide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20191025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191025.